Addus HomeCare (NASDAQ:ADUS) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Addus HomeCare (NASDAQ:ADUS) announced its quarterly earnings data on Monday. The company reported $1.30 earnings per share for the quarter, beating analysts’ consensus estimates of $1.28 by $0.02, Briefing.com reports. The firm had revenue of $289.80 million for the quarter, compared to analyst estimates of $289.42 million. Addus HomeCare had a net margin of 6.18% and a return on equity of 9.81%. The business’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same period in the previous year, the company earned $1.03 earnings per share.

Addus HomeCare Price Performance

NASDAQ:ADUS opened at $130.01 on Wednesday. The company has a 50 day moving average price of $129.77 and a 200-day moving average price of $120.85. Addus HomeCare has a 1-year low of $81.51 and a 1-year high of $136.12. The firm has a market cap of $2.35 billion, a price-to-earnings ratio of 28.41, a price-to-earnings-growth ratio of 2.29 and a beta of 1.04.

Insider Buying and Selling

In other Addus HomeCare news, Director Esteban Lopez sold 500 shares of Addus HomeCare stock in a transaction on Wednesday, September 4th. The shares were sold at an average price of $130.03, for a total value of $65,015.00. Following the completion of the transaction, the director now owns 3,866 shares of the company’s stock, valued at approximately $502,695.98. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other news, EVP Michael D. Wattenbarger sold 21,917 shares of the company’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the completion of the transaction, the executive vice president now directly owns 7,215 shares of the company’s stock, valued at $961,687.35. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Esteban Lopez sold 500 shares of Addus HomeCare stock in a transaction on Wednesday, September 4th. The shares were sold at an average price of $130.03, for a total transaction of $65,015.00. Following the completion of the sale, the director now directly owns 3,866 shares in the company, valued at $502,695.98. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 22,917 shares of company stock valued at $3,050,082. Corporate insiders own 4.60% of the company’s stock.

Analyst Ratings Changes

Several analysts have weighed in on the company. Stephens reiterated an “overweight” rating and set a $138.00 price target on shares of Addus HomeCare in a research note on Tuesday, August 6th. Royal Bank of Canada reiterated an “outperform” rating and issued a $141.00 target price on shares of Addus HomeCare in a research report on Tuesday, September 3rd. Oppenheimer raised their price target on shares of Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a research report on Monday, September 23rd. Macquarie restated an “outperform” rating and set a $139.00 price objective on shares of Addus HomeCare in a research note on Monday. Finally, TD Cowen increased their price objective on shares of Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a research note on Thursday, August 8th. One analyst has rated the stock with a sell rating, eight have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Addus HomeCare presently has an average rating of “Moderate Buy” and an average target price of $131.38.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.